Lipitor was approved by the FDA in 1996 to lower cholesterol in adults. Recently however, medical studies have shown that Lipitor increases the risk of diabetes in women.
Pfizer, the maker of Lipitor, has generated $125 billion in sales since Lipitor has been on the market. During this same period of time, the FDA instructed Pfizer to put a significant warning on Lipitor regarding diabetes in women. Despite the FDA’s request, Pfizer provided incomplete information and produced an inadequate warning.
Lipitor Litigation: Claims against Pfizer for Failure to Warn
Today, numerous lawsuits are forthcoming in federal court that alleges the cholesterol-lowering drug Lipitor is linked to Type 2 diabetes in women. If you feel you may be eligible for compensation, please contact our law firm without delay. We can help you determine whether you have a valid claim and explain your options.
These lawsuits make various allegations, stating that Pfizer was negligent on several counts. Lawsuits against Lipitor claim that Pfizer:
- Was aware of a diabetes link indicated in some patients; still, the pharmaceutical company represented that Lipitor caused minimal side effects
- Knew or should have known from medical studies, that the extended use of Lipitor increased the chance of onset of Type 2 diabetes in certain patients
- Engaged in negligently marketing Lipitor, as they knew or should have known that their packaging warning was inadequate and provided incomplete information about the risk of diabetes to those who used the drug
- Took no action to examine the accuracy of the inadequate labeling once they became aware that Lipitor posed a safety hazard
- Made no effort to conduct post-market safety studies on Lipitor
Download Our Free Lipitor eBook
If you or a loved one has been injured by Lipitor, or you just want to learn more about this dangerous drug, download our complimentary Lipitor eBook here.
